PubRank

David A Katz

Author PubWeight™ 18.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dual effects of rifampin on the pharmacokinetics of atrasentan. J Clin Pharmacol 2007 1.64
2 High physician concern about malpractice risk predicts more aggressive diagnostic testing in office-based practice. Health Aff (Millwood) 2013 1.27
3 Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925. Int J Neuropsychopharmacol 2009 1.10
4 Barriers to HIV Care and Treatment Among Participants in a Public Health HIV Care Relinkage Program. AIDS Patient Care STDS 2015 1.07
5 ru2hot?: A public health education campaign for men who have sex with men to increase awareness of symptoms of acute HIV infection. Sex Transm Infect 2013 1.05
6 PhRMA white paper on ADME pharmacogenomics. J Clin Pharmacol 2008 0.99
7 A decision support system for cost-effective diagnosis. Artif Intell Med 2010 0.95
8 α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol Med 2012 0.93
9 Evidence for epistasis between SLC6A4 and a chromosome 4 gene as risk factors in major depression. Am J Med Genet B Neuropsychiatr Genet 2010 0.89
10 Seroadaptation among men who have sex with men: emerging research themes. Curr HIV/AIDS Rep 2013 0.89
11 Trends in Serosorting and the Association With HIV/STI Risk Over Time Among Men Who Have Sex With Men. J Acquir Immune Defic Syndr 2016 0.86
12 Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics. Pharmacogenetics 2004 0.86
13 Hospital costs associated with smoking in veterans undergoing general surgery. J Am Coll Surg 2012 0.85
14 A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia. J Clin Psychopharmacol 2011 0.84
15 Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapy. AIDS 2003 0.82
16 Frequency of the frame-shifting CYP2D7 138delT polymorphism in a large, ethnically diverse sample population. Drug Metab Dispos 2007 0.81
17 Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. Pharmacogenet Genomics 2013 0.78
18 Effect of ketoconazole on the pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 and its two active metabolites in healthy volunteers: population analysis of data from a drug-drug interaction study. Drug Metab Dispos 2013 0.78
19 Changes in Condomless Sex and Serosorting Among Men Who Have Sex With Men After HIV Diagnosis. J Acquir Immune Defic Syndr 2016 0.77
20 Comparison of In-Person Versus Telephone Interviews for Early Syphilis and Human Immunodeficiency Virus Partner Services in King County, Washington (2010-2014). Sex Transm Dis 2017 0.75
21 Prediction of successful weight reduction under sibutramine therapy. Pharmacogenetics 2004 0.75
22 Modernizing Field Services for Human Immunodeficiency Virus and Sexually Transmitted Infections in the United States. Sex Transm Dis 2017 0.75
23 Pharmacogenetics: an opportunity for codevelopment of pharmaceuticals and diagnostics. Expert Rev Mol Diagn 2002 0.75
24 Suggestive evidence on chromosomes 2 and 19 for HTR1A-independent linkage of genes to major depression. Neurogenetics 2009 0.75
25 A Single Question to Examine the Prevalence and Protective Effect of Seroadaptive Strategies Among Men Who Have Sex With Men. Sex Transm Dis 2017 0.75
26 Evaluation of an Automated Express Care Triage Model to Identify Clinically Relevant Cases in a Sexually Transmitted Disease Clinic. Sex Transm Dis 2017 0.75
27 Population pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 in healthy volunteers following single and multiple dose regimens. Biopharm Drug Dispos 2014 0.75